- Home
- CCU vs PTGX Comparison
CCU vs PTGX Comparison
Compare CCU & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCU
- PTGX
- Stock Information
- Founded
- CCU 1850
- PTGX 2006
- Country
- CCU Chile
- PTGX United States
- Employees
- CCU N/A
- PTGX N/A
- Industry
- CCU Beverages (Production/Distribution)
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- CCU Consumer Staples
- PTGX Health Care
- Exchange
- CCU Nasdaq
- PTGX Nasdaq
- Market Cap
- CCU 2.4B
- PTGX 3.3B
- IPO Year
- CCU 1992
- PTGX 2016
- Fundamental
- Price
- CCU $12.83
- PTGX $53.00
- Analyst Decision
- CCU Strong Sell
- PTGX Strong Buy
- Analyst Count
- CCU 2
- PTGX 9
- Target Price
- CCU $9.70
- PTGX $67.11
- AVG Volume (30 Days)
- CCU 224.0K
- PTGX 923.4K
- Earning Date
- CCU 08-06-2025
- PTGX 08-05-2025
- Dividend Yield
- CCU 2.13%
- PTGX N/A
- EPS Growth
- CCU 67.38
- PTGX N/A
- EPS
- CCU 0.47
- PTGX 0.86
- Revenue
- CCU $3,126,996,945.00
- PTGX $207,801,000.00
- Revenue This Year
- CCU $9.09
- PTGX N/A
- Revenue Next Year
- CCU $4.83
- PTGX $53.09
- P/E Ratio
- CCU $13.89
- PTGX $61.48
- Revenue Growth
- CCU 15.38
- PTGX N/A
- 52 Week Low
- CCU $10.00
- PTGX $32.50
- 52 Week High
- CCU $15.75
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- CCU 43.52
- PTGX 53.99
- Support Level
- CCU $12.82
- PTGX $49.38
- Resistance Level
- CCU $13.60
- PTGX $51.51
- Average True Range (ATR)
- CCU 0.33
- PTGX 2.02
- MACD
- CCU 0.06
- PTGX -0.39
- Stochastic Oscillator
- CCU 40.71
- PTGX 46.09
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.